MSE
IONS icon

MUFG Securities EMEA’s Ionis Pharmaceuticals IONS Stock Holding History

MUFG Securities EMEA’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200,000
Closed -$6.09M – 180
2021
Q4 		$6.09M Buy
+200,000
New +$6.3M 0.09% 79
2020
Q4 		– Sell
-12,374
Closed -$587K – 421
2020
Q3 		$587K Buy
+12,374
New +$687K 0.01% 336
2019
Q3 		– Sell
-47,111
Closed -$3.03M – 395
2019
Q2 		$3.03M Hold
47,111
– – 0.03% 237
2019
Q1 		$3.82M Buy
+47,111
New +$3.04M 0.04% 238

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

MUFG Securities EMEA's IONS Position: Q1 2022 in Review

MUFG Securities EMEA sold out of Ionis Pharmaceuticals (IONS) in Q1 2022, closing a stake of 200,000 shares — an estimated $6.09M sold.

MUFG Securities EMEA first reported a position in IONS in Q1 2019 and held it in 4 quarters. The position peaked at $6.09M in Q4 2021. 332 funds tracked by Wall St. Rank hold IONS as of Q1 2022.

  • MUFG Securities EMEA reported no remaining Ionis Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • MUFG Securities EMEA sold 200,000 Ionis Pharmaceuticals shares in Q1 2022, an estimated $6.09M.
  • MUFG Securities EMEA first reported a position in Ionis Pharmaceuticals in Q1 2019 and held it in 4 quarters.
  • MUFG Securities EMEA's Ionis Pharmaceuticals position peaked at $6.09M in Q4 2021.
  • 332 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2022.

Based on MUFG Securities EMEA's 13F filing for Q1 2022, filed 10 May 2022.